Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study
Titel:
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study
Auteur:
Escrivá-de-Romani, Santiago Cejalvo, Juan M Alba, Emilio Friedmann, Jennifer Rodríguez-Lescure, Álvaro Savard, Marie-France Pezo, Rossanna C Gion, Maria Ruiz-Borrego, Manuel Hamilton, Erika Pluard, Timothy Webster, Marc Beeram, Muralidhar Linden, Hannah Saura, Cristina Shpektor, Diana Salim, Bob Harvey, Phoebe Hurvitz, Sara A